The most extensively studied FABP in PCa, FABP5, promotes PCa cell and/or xenograft tumor growth, with inhibition of both PPARβ/δ and PPARγ suppressing these effects [30, 33, 69, 70, 71, 72, 73]. Here, PPARG is linked to neoplasm.